Found: 55
Select item for more details and to access through your institution.
Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 6, p. 1475, doi. 10.1093/jac/dks047
- By:
- Publication type:
- Article
Improved V3 genotyping with duplicate PCR amplification for determining HIV-1 tropism.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients--authors response.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 63, n. 5, p. 1080, doi. 10.1093/jac/dkp064
- By:
- Publication type:
- Article
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 63, n. 2, p. 380
- By:
- Publication type:
- Article
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).
- Published in:
- 2000
- By:
- Publication type:
- journal article
Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study.
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. P29, doi. 10.1186/1758-2652-13-S4-P29
- By:
- Publication type:
- Article
Prevalence of resistance and HIV-1 protease mutation patterns after failures with fosamprenavir-containing regimens.
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. P136, doi. 10.1186/1758-2652-13-S4-P136
- By:
- Publication type:
- Article
Darunavir resistance spectrum in darunavir-naᵢve patients harboring virological failure to antiretroviral therapy.
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. P133, doi. 10.1186/1758-2652-13-S4-P133
- By:
- Publication type:
- Article
Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study.
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Prevalence of resistance and HIV-1 protease mutation patterns after failures with fosamprenavir-containing regimens.
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Darunavir resistance spectrum in darunavir-naive patients harboring virological failure to antiretroviral therapy.
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Persistent Poliovirus Infection: Development of New Models with Cell Lines<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1995, v. 753, n. 1, p. 370, doi. 10.1111/j.1749-6632.1995.tb27564.x
- By:
- Publication type:
- Article
National survey of the prevalence and conditions of selection of HIV-1 reverse transcriptase K70E mutation.
- Published in:
- Journal of Medical Virology, 2008, v. 80, n. 5, p. 762, doi. 10.1002/jmv.21158
- By:
- Publication type:
- Article
CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity.
- Published in:
- International Immunology, 1998, v. 10, n. 3, p. 311, doi. 10.1093/intimm/10.3.311
- By:
- Publication type:
- Article
Efficacy of raltegravir switching strategies in HIV-infected patients with suppressed viraemia according to the genotypic sensitivity score.
- Published in:
- Infection, 2014, v. 42, n. 2, p. 295, doi. 10.1007/s15010-013-0542-8
- By:
- Publication type:
- Article
Lack of evidence of an association between HHV-8 and multiple myeloma.
- Published in:
- 1998
- By:
- Publication type:
- Letter
Factors Associated With Virological Failure in HIV-1-Infected Patients Receiving Darunavir/Ritonavir Monotherapy.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Relationship between the quantity of kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Transactivation of the metallothionein promoter in cisplatin-resistant cancer cells: a specific gene therapy strategy.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen*.
- Published in:
- Journal of Medical Virology, 2001, v. 65, n. 3, p. 445, doi. 10.1002/jmv.2055
- By:
- Publication type:
- Article
Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infection.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Disparities in HIV-1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populations.
- Published in:
- HIV Medicine, 2017, v. 18, n. 9, p. 696, doi. 10.1111/hiv.12508
- By:
- Publication type:
- Article
Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort data.
- Published in:
- HIV Medicine, 2015, v. 16, n. 5, p. 297, doi. 10.1111/hiv.12218
- By:
- Publication type:
- Article
Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients S Lambert-Niclot et al. Atazanavir inhibitory quotient in first-line therapy
- Published in:
- HIV Medicine, 2010, v. 11, n. 10, p. 666, doi. 10.1111/j.1468-1293.2010.00839.x
- By:
- Publication type:
- Article
Identification of new genotypic cut-off levels to predict the efficacy of lopinavir/ritonavir and darunavir/ritonavir in the TITAN trial.
- Published in:
- HIV Medicine, 2009, v. 10, n. 10, p. 620, doi. 10.1111/j.1468-1293.2009.00734.x
- By:
- Publication type:
- Article
Stability of HIV RNA in plasma specimens stored at different temperatures.
- Published in:
- HIV Medicine, 2008, v. 9, n. 9, p. 790, doi. 10.1111/j.1468-1293.2008.00632.x
- By:
- Publication type:
- Article
Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot study.
- Published in:
- HIV Medicine, 2008, v. 9, n. 9, p. 738, doi. 10.1111/j.1468-1293.2008.00616.x
- By:
- Publication type:
- Article
Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor-sparing therapy in patients with lipoatrophy: results from the 96-week randomized ANRS 108 NoNuke Trial.
- Published in:
- HIV Medicine, 2008, v. 9, n. 8, p. 625, doi. 10.1111/j.1468-1293.2008.00606.x
- By:
- Publication type:
- Article
Comparison of two genotypic algorithms to determine HIV-1 tropism.
- Published in:
- HIV Medicine, 2008, v. 9, n. 1, p. 1, doi. 10.1111/j.1468-1293.2008.00518.x
- By:
- Publication type:
- Article
Evaluation of the use of dried spots and of different storage conditions of plasma for HIV-1 RNA quantification.
- Published in:
- HIV Medicine, 2007, v. 8, n. 6, p. 396, doi. 10.1111/j.1468-1293.2007.00484.x
- By:
- Publication type:
- Article
GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapy.
- Published in:
- HIV Medicine, 2004, v. 5, n. 5, p. 352, doi. 10.1111/j.1468-1293.2004.00234.x
- By:
- Publication type:
- Article
Quantitative analysis of human mitochondrial DNA using a real-time PCR assay.
- Published in:
- HIV Medicine, 2003, v. 4, n. 3, p. 287, doi. 10.1046/j.1468-1293.2003.00158.x
- By:
- Publication type:
- Article
P-glycoprotein in blood CD4 cells of HIV-1-infected patients treated with protease inhibitors.
- Published in:
- HIV Medicine, 2003, v. 4, n. 1, p. 67, doi. 10.1046/j.1468-1293.2003.00134.x
- By:
- Publication type:
- Article
MIKADO: a multicentre, open-label pilot study to evaluate the antiretroviral activity and safety of saquinavir with stavudine and zalcitabine.
- Published in:
- HIV Medicine, 2001, v. 2, n. 1, p. 20, doi. 10.1046/j.1468-1293.2001.00046.x
- By:
- Publication type:
- Article
Markov modelling of changes in HIV-specific cytotoxic T-lymphocyte responses with time in untreated HIV-1 infected patients.
- Published in:
- Statistics in Medicine, 2003, v. 22, n. 10, p. 1675, doi. 10.1002/sim.1404
- By:
- Publication type:
- Article
The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma.
- Published in:
- British Journal of Dermatology, 1999, v. 140, n. 5, p. 875, doi. 10.1046/j.1365-2133.1999.02818.x
- By:
- Publication type:
- Article
Lack of evidence of human herpesvirus 8 DNA sequences in HIV-negative patients with various lymphoproliferative disorders of the skin.
- Published in:
- British Journal of Dermatology, 1997, v. 136, n. 6, p. 827, doi. 10.1111/j.1365-2133.1997.tb03920.x
- By:
- Publication type:
- Article
Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dynamics of drug resistance-associated mutations in HIV-1 DNA reverse transcriptase sequence during effective ART.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combination.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Rapid plasma viral suppression in naive HIV-infected patients with high CD4 cells and low viraemia initiating a dual nucleoside reverse transcriptase inhibitor strategy: a proof-of-concept study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 12, p. 3356, doi. 10.1093/jac/dku265
- By:
- Publication type:
- Article
High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in Mali.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article